Lateral lymph node recurrence and induction chemotherapy 69 CHAPTER 4 17. Fujita S, AkasuT, Mizusawa J, et al. Postoperativemorbidity andmortality aftermesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results fromamulticentre, randomised controlled, non-inferiority trial. Lancet Oncol. 2012;13:616–621. 18. Kim TH, Jeong SY, Choi DH, et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol. 2008;15:729–737. 19. Kim TG, Park W, Choi DH, et al. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients. Int J Colorectal Dis. 2014;29:193–200. 20. Kim MJ, Kim TH, Kim DY, et al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J Surg Oncol. 2015;111:459–464. 21. Oh HK, Kang SB, Lee SM, et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection inmid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol. 2014;21:2280–2287. 22. LimSB, YuCS, KimCW, et al. Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Int J Colorectal Dis. 2013;28:1667–1674. 23. Akiyoshi T, UenoM,MatsuedaK, et al. Selective lateral pelvic lymphnodedissection inpatientswith advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol. 2014;21:189–196.
RkJQdWJsaXNoZXIy MTk4NDMw